Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Short-term Investments (2021 - 2025)

Historic Short-term Investments for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $331.5 million.

  • Krystal Biotech's Short-term Investments rose 3120.3% to $331.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $331.5 million, marking a year-over-year increase of 3120.3%. This contributed to the annual value of $331.5 million for FY2025, which is 3120.3% up from last year.
  • Per Krystal Biotech's latest filing, its Short-term Investments stood at $331.5 million for Q4 2025, which was up 3120.3% from $338.5 million recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Short-term Investments registered a high of $338.5 million during Q3 2025, and its lowest value of $1.2 million during Q1 2021.
  • Over the past 5 years, Krystal Biotech's median Short-term Investments value was $207.4 million (recorded in 2022), while the average stood at $196.5 million.
  • Per our database at Business Quant, Krystal Biotech's Short-term Investments skyrocketed by 1314751.6% in 2022 and then crashed by 1998.47% in 2023.
  • Krystal Biotech's Short-term Investments (Quarter) stood at $96.8 million in 2021, then soared by 124.34% to $217.3 million in 2022, then decreased by 19.98% to $173.8 million in 2023, then soared by 45.33% to $252.7 million in 2024, then soared by 31.2% to $331.5 million in 2025.
  • Its Short-term Investments stands at $331.5 million for Q4 2025, versus $338.5 million for Q3 2025 and $328.2 million for Q2 2025.